Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules.

Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as opioids and opioid derivatives.

Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to targets, such as viruses (e.g. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)), and/or antigens thereof (e.g. Spike protein and/or its subunits).

Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as opioids and opioid derivatives.

Abstract: The present invention describes the use of compounds to stimulate nerve cell growth in adult brain. In one aspect, the present invention comprises a method to increase neuronal replacement and repair in an individual comprising administering at least one atypical neuroleptic to the individual in such a manner as to increase neurogenesis by a predetermined amount in at least one region of the brain. The compounds of the present invention may be used to treat conditions associated with loss of brain function such as loss of memory, schizophrenia, Alzheimer's disease, Parkinson's disease, Attention Deficit Disorder, and stroke.